CWM
BIIB icon

Confluence Wealth Management’s Biogen BIIB Stock Holding History

Confluence Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$532K Sell
2,284
-182
-7% -$50.8K 0.26% 82
2020
Q2 		$660K Buy
2,466
+112
+5% +$33.7K 0.31% 67
2020
Q1 		$745K Buy
2,354
+215
+10% +$65.2K 0.42% 56
2019
Q4 		$635K Sell
2,139
-145
-6% -$40.2K 0.29% 72
2019
Q3 		$532K Sell
2,284
-114
-5% -$26.5K 0.26% 82
2019
Q2 		$561K Buy
2,398
+23
+1% +$5.31K 0.27% 75
2019
Q1 		$561K Buy
2,375
+59
+3% +$18.6K 0.28% 75
2018
Q4 		$697K Sell
2,316
-34
-1% -$10.9K 0.39% 63
2018
Q3 		$830K Buy
2,350
+10
+0.4% +$3.44K 0.43% 57
2018
Q2 		$679K Buy
2,340
+14
+0.6% +$3.94K 0.36% 64
2018
Q1 		$637K Sell
2,326
-7
-0.3% -$2.17K 0.33% 68
2017
Q4 		$743K Sell
2,333
-40
-2% -$12.8K 0.35% 67
2017
Q3 		$743K Buy
2,373
+22
+0.9% +$6.51K 0.36% 65
2017
Q2 		$638K Buy
2,351
+71
+3% +$18.8K 0.31% 73
2017
Q1 		$623K Sell
2,280
-481
-17% -$136K 0.31% 72
2016
Q4 		$783K Sell
2,761
-5
-0.2% -$1.48K 0.39% 64
2016
Q3 		$866K Buy
2,766
+1,109
+67% +$328K 0.42% 61
2016
Q2 		$401K Sell
1,657
-1
-0.1% -$264 0.2% 94
2016
Q1 		$432K Buy
1,658
+759
+84% +$200K 0.2% 100
2015
Q4 		$275K Sell
899
-943
-51% -$271K 0.13% 113
2015
Q3 		$538K Buy
1,842
+90
+5% +$29.7K 0.29% 77
2015
Q2 		$708K Sell
1,752
-28
-2% -$11.2K 0.39% 61
2015
Q1 		$752K Buy
+1,780
New +$702K 0.44% 58

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Confluence Wealth Management's BIIB Position: Q3 2020 in Review

Confluence Wealth Management reduced its Biogen (BIIB) stake by 7.4% in Q3 2020, selling an estimated $50.8K and leaving 2,284 shares worth $532K. The position accounts for 0.26% of the portfolio, ranked #82.

Confluence Wealth Management first reported a position in BIIB in Q1 2015 and has held it in 23 quarters since. The position peaked at $866K in Q3 2016. 1,051 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

  • Confluence Wealth Management held 2,284 shares of Biogen worth $532K as of Q3 2020.
  • Confluence Wealth Management sold 182 Biogen shares in Q3 2020, an estimated $50.8K.
  • Biogen made up 0.26% of Confluence Wealth Management's portfolio in Q3 2020, its #82 holding.
  • Confluence Wealth Management first reported a position in Biogen in Q1 2015 and has held it in 23 quarters since.
  • Confluence Wealth Management's Biogen position peaked at $866K in Q3 2016.
  • 1,051 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on Confluence Wealth Management's 13F filing for Q3 2020, filed 26 Oct 2020.